欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/2881/002
药品名称Levobupivacaïne Fresenius Kabi 1.25 mg/ml
活性成分
    • Levobupivacaine hydrochloride 1.25 mg/ml
剂型Solution for infusion
上市许可持有人Fresenius Kabi Deutschland GmbH Borkenberg 14 61440 Oberursel
参考成员国 - 产品名称Netherlands (NL)
Levobupivacaïne Fresenius Kabi 1,25 mg/ml, oplossing voor infusie
互认成员国 - 产品名称
    • Belgium (BE)
      Levobupivacaïne Fresenius Kabi 1,25mg/ml oplossing voor infusie
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Slovenia (SI)
      Levobupivakain Kabi 1,25 mg/ml raztopina za infundiranje
许可日期2014/04/21
最近更新日期2024/10/28
药物ATC编码
    • N01BB10 levobupivacaine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase